Registration for the 23rd Annual Meeting is now open! Non-members are invited to apply for membership when they register to earn the member discount on their registration. As always, Associate Members who are first and presenting authors on an abstract at the Annual Meeting receive free registration.
Exhibitors looking to secure registration should contact their ASGCT representative.
After careful consideration of the ongoing spread of COVID-19 overseas and in the United States, the American Society of Gene & Cell Therapy (ASGCT) Board of Directors has decided not to conduct ASGCT’s 2020 Annual Meeting in Boston, Massachusetts scheduled for May 2020.
ASGCT has come to the conclusion that it is only possible to fulfill the Society’s mission by hosting the 23rd Annual Meeting virtually and as-scheduled.
It is our hope that the ability to share innovative science, connect virtually with peers from around the world, and learn from one another will bring forth a sense of renewed optimism in light of the continuing challenges ahead. The new rate schedule is listed below:
New for 2020, ASGCT is changing the Pre-Meeting Workshop program to offer more half-day sessions. All Pre-Meeting Workshops will take place live in a virtual meeting environment on Monday, May 11, 2020. Each workshop has an individual registration rate, and attendees may register for any or all workshops independent of, or in addition to, registration for the Annual Meeting.
Pre-Meeting Workshops (Held on May 11)
The CAR T and Related Immune Effector Cell Therapies Workshop will feature discussions of the current state of CAR T therapeutic approaches in light of recent FDA approvals with updates on clinical long term follow-up gene editing and going beyond autologous CAR-T cells for cancer.
The Clinical Trials Training workshop I will address the development of early stage clinical trials, specifically covering the journey from preclinical development to clinical trial implementation and is intended primarily for early stage investigators.
The Commercialization workshop I will focus on the regulatory pathways to the commercialization of gene and cell therapy products with discussions covering the harmonization of global regulatory approaches.
The Stem Cell Therapies workshop will feature a diverse offering of presentations covering a broad array of topics in stem cell therapies, including scientific advances and clinical applications.
The Clinical Trials Training workshop II will provide an in-depth discussion, including case studies and first-hand accounts, of the development and launch of gene therapy clinical trials, both in academia and in commercial settings.
The Commercialization workshop II will focus on the unique challenges emerging technologies pose in designing acceptable business models to maximize patient access and discussions of value based pricing and reimbursement for gene therapies.
The Gene Editing workshop will provide an overview of current gene editing technologies and approaches, emerging uses and applications, with sessions highlighting junior investigators and clinical gene editing programs.
The Oncolytic Viruses workshop will feature overviews of the recent advances in oncolytics, including oncolytic viruses, cancer vaccines, and novel combination immuno-oncologic therapies.
The Viral Vector Development workshop will provide an in-depth discussion of the advances as well as the challenges in vector development and manufacturing, including GMP production.
Please contact us at ASGCT@showcare.com. We must receive this information in writing. Your cancellation is subject to a refund schedule and $75 processing fee.
All cancellations must be sent in writing via e-mail to the conference registrar. Please e-mail cancellations, if possible, and expect confirmation within two business days.
Editorial and broadcast staff media members receive complimentary registration to the ASGCT 23rd Annual Meeting. Advertising, publishing, and/or marketing representatives cannot register as media. For media registration questions or issues visit the Media Registration page, or contact ASGCT Senior Manager of Communications Alex Wendland.
Abstract Notifications Sent
April 6, 2020
April 28, 2020
23rd ASGCT Annual Meeting
May 12 – 15, 2020
Use the ASGCT app on your mobile device to build your schedule, read the abstracts (released on April 28), and guide your way through the Hynes Convention Center.
Hynes Convention Center
900 Boylston St.
Boston, MA 02115